Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03772951Phase 4Completed
Phase 4, randomised trial in schizophrenia (2 arms), sponsored by Shanghai Mental Health Center. Primary endpoints: Positive and Negative Syndrome Scale at 12 weeks and Brain Derived Neurotrophic Factor at 12 weeks. Started Jan 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03772951.